RORB and gastric cancer: As shown in Table 1, low RORβ mRNA expression was correlated with a better prognosis in all clinical stages of GC [stage 1: HR = 3.63, 95% CI: (1.35–9.75), P = 0.0063; stage 2: HR = 2.71, 95% CI: (1.3–5.67), P = 0.0085; stage 3: HR = 1.65, 95% CI: (1.17–2.32), P = 0.0036; stage 4: HR = 1.61, 95% CI: (1.1–2.37), P = 0.014].